SOPHiA GENETICS Statistics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $212.83 million. The enterprise value is $174.43 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SOPHiA GENETICS has 66.82 million shares outstanding. The number of shares has increased by 2.20% in one year.
| Current Share Class | 66.82M |
| Shares Outstanding | 66.82M |
| Shares Change (YoY) | +2.20% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 6.53% |
| Owned by Institutions (%) | 27.06% |
| Float | 52.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.15 |
| Forward PS | 2.72 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 3.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.35.
| Current Ratio | 3.11 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.29 |
Financial Efficiency
Return on equity (ROE) is -60.75% and return on invested capital (ROIC) is -30.07%.
| Return on Equity (ROE) | -60.75% |
| Return on Assets (ROA) | -24.41% |
| Return on Invested Capital (ROIC) | -30.07% |
| Return on Capital Employed (ROCE) | -54.21% |
| Revenue Per Employee | $158,801 |
| Profits Per Employee | -$156,440 |
| Employee Count | 423 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 3.87 |
Taxes
In the past 12 months, SOPHiA GENETICS has paid $1.41 million in taxes.
| Income Tax | 1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.41% in the last 52 weeks. The beta is 1.03, so SOPHiA GENETICS's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -32.41% |
| 50-Day Moving Average | 3.08 |
| 200-Day Moving Average | 3.48 |
| Relative Strength Index (RSI) | 54.75 |
| Average Volume (20 Days) | 27,269 |
Short Selling Information
The latest short interest is 43,062, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 43,062 |
| Short Previous Month | 47,243 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.08% |
| Short Ratio (days to cover) | 1.31 |
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of $67.17 million and -$66.17 million in losses. Loss per share was -$1.00.
| Revenue | 67.17M |
| Gross Profit | 45.74M |
| Operating Income | -63.85M |
| Pretax Income | -66.00M |
| Net Income | -66.17M |
| EBITDA | -62.19M |
| EBIT | -63.85M |
| Loss Per Share | -$1.00 |
Full Income StatementBalance Sheet
The company has $68.53 million in cash and $30.13 million in debt, giving a net cash position of $38.40 million or $0.57 per share.
| Cash & Cash Equivalents | 68.53M |
| Total Debt | 30.13M |
| Net Cash | 38.40M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 85.61M |
| Book Value Per Share | 1.28 |
| Working Capital | 61.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.93 million and capital expenditures -$145,000, giving a free cash flow of -$39.07 million.
| Operating Cash Flow | -38.93M |
| Capital Expenditures | -145,000 |
| Free Cash Flow | -39.07M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
Gross margin is 68.09%, with operating and profit margins of -95.05% and -98.51%.
| Gross Margin | 68.09% |
| Operating Margin | -95.05% |
| Pretax Margin | -96.41% |
| Profit Margin | -98.51% |
| EBITDA Margin | -92.58% |
| EBIT Margin | -95.05% |
| FCF Margin | n/a |
Dividends & Yields
SOPHiA GENETICS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.20% |
| Shareholder Yield | -2.20% |
| Earnings Yield | -31.09% |
| FCF Yield | -18.36% |
Analyst Forecast
The average price target for SOPHiA GENETICS is $6.50, which is 104.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 104.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 25.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SOPHiA GENETICS has an Altman Z-Score of -2.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.28 |
| Piotroski F-Score | 3 |